Search Results - "Fuchs CD"

The secretory protein, CLCF1, improves cholestatic liver disease by inhibiting hepatic bile acid synthesis and promoting bile acid excretion.

Authors: Liu, Man Su, Yingxi Hu, Yujie et al.

Source: Communications Biology. 3/16/2026, Vol. 9 Issue 1, p1-18. 18p.

Exploring the mechanism of ursodeoxycholic acid in the treatment of osteoarthritis based on network pharmacology, molecular docking, and molecular dynamics simulations.

Authors: Li, Xin Xiong, Jinhe

Source: European Journal of Inflammation. 6/15/2026, Vol. 24, p1-22. 22p.

Successful AAV8 gene therapy on hepatic ex situ machine perfusion for mitochondrial neurogastrointestinal encephalomyopathy.

Authors: Brevini T Swift L Reynolds H et al.

Source: Journal of hepatology [J Hepatol] 2025 Nov; Vol. 83 (5), pp. 1218-1225. Date of Electronic Publication: 2025 Aug 06.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE

Stress study of elafibranor and characterization of its degradation impurities using HPLC and LC-MS/MS techniques.

Authors: Bhojegowda, Madhusudana Reddy Muthukurpalya Reddy, Thoorpugadda Raja Palakeeti, Babji et al.

Source: Journal of Applied Pharmaceutical Science. Mar2026, Vol. 16 Issue 3, p301-311. 11p.

Aberrant miR-378 expression promotes hepatic lipid accumulation via hijacking the bile acid-regulated autophagy.

Authors: Niu, Zhoumin Yan, Ying Liu, Wei et al.

Source: Life Metabolism. Feb2026, Vol. 5 Issue 1, p1-15. 15p.

Bidirectional interplay between gut and liver in inflammatory bowel disease and hepatobiliary conditions.

Authors: Abdulla A Sheikhnoor AM Ferrao K et al.

Source: Clinical and experimental medicine [Clin Exp Med] 2026 Apr 07; Vol. 26 (1). Date of Electronic Publication: 2026 Apr 07.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

Modelling the potential use of pre-exposure prophylaxis to reduce nosocomial SARS-CoV-2 transmission.

Authors: Stewart, Lauren Evans, Stephanie Brevini, Teresa et al.

Source: PLoS Computational Biology. 8/5/2025, Vol. 21 Issue 8, p1-17. 17p.

Time-Dependent Differential Effects of SARS CoV 2 Spike Protein in Lung and Colon Epithelial Cell Lines.

Authors: Yilmaz, Aysegul Yaka, Utku Turk, Seyhan et al.

Source: Jundishapur Journal of Microbiology. Jan2026, Vol. 19 Issue 1, p1-11. 11p.

Update of safety profile of bile acid sequestrants: A real-world pharmacovigilance study of the FDA adverse event reporting system.

Authors: Chen, Wangqi Xie, Yuxia Li, Qinghua et al.

Source: PLoS ONE. 7/15/2025, Vol. 20 Issue 7, p1-17. 17p.

Fuzheng Huayu formula ameliorates chronic cholestatic liver injury by upregulating PPARa in mice.

Authors: Zhang Z Tang EQ Li CH et al.

Source: Chinese medicine [Chin Med] 2026 Mar 18; Vol. 21 (1). Date of Electronic Publication: 2026 Mar 18.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101265109 Publication Model: Electronic Cited Medium: Print ISSN: 1749-8546 (Print) Linking ISSN: 17498546 NLM ISO Abbreviation: Chin Med Subsets: PubMed not MEDLINE

黄芪皂苷Ⅰ和毛蕊异黄酮在胆汁淤积性肝纤维化小鼠模型中的调控作用分析

Alternate Title: Regulatory effect of astragaloside Ⅰ and calycosin on a mouse model of cholestatic liver fibrosis.

Authors: 姜, 小钰 刘, 伟 陈, 佳美 et al.

Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. May2026, Vol. 42 Issue 5, p1083-1092. 10p.

Comparative effects of aerobic and resistance exercise on bile acid profiles and liver function in patients with non-alcoholic fatty liver disease.

Authors: Shi, Jiasen Cui, Junchao Zheng, Tianlei et al.

Source: BMC Gastroenterology. 4/10/2025, Vol. 25 Issue 1, p1-13. 13p.

Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond.

Authors: Qasim, Bushra Kumari, Hina Kashif, Syeda Naveera et al.

Source: Egyptian Liver Journal. 10/15/2025, Vol. 15 Issue 1, p1-14. 14p.

Elucidating the pathogenesis of rumen abnormal adipose deposition in high-concentrate fed Hu sheep through transcriptomic profiling.

Authors: Xu, Yunfei Wang, Guoxiu Wang, Weimin et al.

Source: BMC Veterinary Research. 10/2/2025, Vol. 21 Issue 1, p1-13. 13p.

Drug-endobiotic interaction effect of UGT enzymes inhibition on systemic bile acids levels in rat.

Authors: Mullapudi, T. V. Radhakrishna Ravi, Punna Rao

Source: Journal of Applied Pharmaceutical Science. Sep2025, Vol. 15 Issue 9, p097-105. 9p.

Taurine alleviated paraquat-induced oxidative stress and gut-liver axis damage in weaned piglets by regulating the Nrf2/Keap1 and TLR4/NF-κB signaling pathways.

Authors: Chen, Chen Qi, Min Zhang, Weilong et al.

Source: Journal of Animal Science & Biotechnology. 8/18/2025, Vol. 16 Issue 1, p1-23. 23p.

Longitudinal outcomes of obeticholic acid therapy in ursodiol‐nonresponsive primary biliary cholangitis: Stratifying the impact of add‐on fibrates in real‐world practice.

Authors: Gómez, E. Montero, J. L. Molina, E. et al.

Source: Alimentary Pharmacology & Therapeutics. Jun2024, Vol. 59 Issue 12, p1604-1615. 12p.

Modulation of host lipid metabolism by virus infection leads to exoskeleton damage in shrimp.

Authors: Wang, Xin-Xin Ding, Ming-Jie Gao, Jie et al.

Source: PLoS Pathogens. 5/13/2024, Vol. 20 Issue 5, p1-22. 22p.

Technology-enabled insights into SLC transporters in MAFLD: redefining the multi-hit pathogenesis and therapeutic landscape.

Authors: Tawai J Xiong J

Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2026 Jul; Vol. 47 (7), pp. 1733-1748. Date of Electronic Publication: 2026 Mar 04.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE

Calculus Bovis ameliorates primary sclerosing cholangitis via a dual-pronged mechanism restoring bile acid and lipid homeostasis in the gut-liver axis.

Authors: Gong X Chen Y Zhao T et al.

Source: Chinese medicine [Chin Med] 2026 Jun 08; Vol. 21 (1). Date of Electronic Publication: 2026 Jun 08.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101265109 Publication Model: Electronic Cited Medium: Print ISSN: 1749-8546 (Print) Linking ISSN: 17498546 NLM ISO Abbreviation: Chin Med Subsets: PubMed not MEDLINE